These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 17848099

  • 21. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
    Helfand MS, Taracila MA, Totir MA, Bonomo RA, Buynak JD, van den Akker F, Carey PR.
    Biochemistry; 2007 Jul 24; 46(29):8689-99. PubMed ID: 17595114
    [Abstract] [Full Text] [Related]

  • 22. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H.
    Arzneimittelforschung; 1987 Oct 24; 37(10):1116-9. PubMed ID: 3501722
    [Abstract] [Full Text] [Related]

  • 23. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
    Papp-Wallace KM, Winkler ML, Taracila MA, Bonomo RA.
    Antimicrob Agents Chemother; 2015 Jul 24; 59(7):3710-7. PubMed ID: 25666153
    [Abstract] [Full Text] [Related]

  • 24. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
    Papp-Wallace KM, Taracila M, Hornick JM, Hujer AM, Hujer KM, Distler AM, Endimiani A, Bonomo RA.
    Antimicrob Agents Chemother; 2010 Jul 24; 54(7):2867-77. PubMed ID: 20421396
    [Abstract] [Full Text] [Related]

  • 25. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML, Papp-Wallace KM, Taracila MA, Bonomo RA.
    Antimicrob Agents Chemother; 2015 Jul 24; 59(7):3700-9. PubMed ID: 25691639
    [Abstract] [Full Text] [Related]

  • 26. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
    Sun T, Bethel CR, Bonomo RA, Knox JR.
    Biochemistry; 2004 Nov 09; 43(44):14111-7. PubMed ID: 15518561
    [Abstract] [Full Text] [Related]

  • 27. Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: Raman crystallographic evidence.
    Kalp M, Totir MA, Buynak JD, Carey PR.
    J Am Chem Soc; 2009 Feb 18; 131(6):2338-47. PubMed ID: 19161282
    [Abstract] [Full Text] [Related]

  • 28. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar 18; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 29. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains.
    Brauers J, Frank U, Kresken M, Rodloff AC, Seifert H.
    Clin Microbiol Infect; 2005 Jan 18; 11(1):24-30. PubMed ID: 15649300
    [Abstract] [Full Text] [Related]

  • 30. [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production].
    del Mar Pérez-Moreno M, Pous-Miralles G, Romera-Sastre G, Panisello-Bertomeu JM, Jardí-Baiges AM, Zarazoga-López J.
    Enferm Infecc Microbiol Clin; 1997 Nov 18; 15(9):477-81. PubMed ID: 9527373
    [Abstract] [Full Text] [Related]

  • 31. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ, Cartelle M, Mallo S, Beceiro A, Pérez A, Villanueva R, Romero A, Bonnet R, Bou G.
    J Antimicrob Chemother; 2008 Apr 18; 61(4):792-7. PubMed ID: 18281307
    [Abstract] [Full Text] [Related]

  • 32. Evolution of beta-lactamase inhibitors.
    Jackson D.
    Pharmacotherapy; 1991 Apr 18; 11(2 ( Pt 2)):37S-39S. PubMed ID: 2041830
    [Abstract] [Full Text] [Related]

  • 33. The kinetics of SHV-2 plasmid-mediated beta-lactamase compared to those of the parent enzyme from which it is derived.
    Labia R, Morand A, Tiwari K, Pitton JS, Sirot D, Sirot J, Ben Yaghlane H, Boujenah A.
    Drugs Exp Clin Res; 1988 Apr 18; 14(5):335-9. PubMed ID: 3065020
    [Abstract] [Full Text] [Related]

  • 34. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.
    Oliver A, Pérez-Vázquez M, Martínez-Ferrer M, Baquero F, De Rafael L, Cantón R.
    Antimicrob Agents Chemother; 1999 Apr 18; 43(4):862-7. PubMed ID: 10103192
    [Abstract] [Full Text] [Related]

  • 35. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME, Fu KP, Gregory FJ, Hung PP.
    Drugs Exp Clin Res; 1987 Apr 18; 13(3):145-8. PubMed ID: 3040368
    [Abstract] [Full Text] [Related]

  • 36. Novel imidazole substituted 6-methylidene-penems as broad-spectrum beta-lactamase inhibitors.
    Venkatesan AM, Agarwal A, Abe T, Ushirogochi H, Yamamura I, Kumagai T, Petersen PJ, Weiss WJ, Lenoy E, Yang Y, Shlaes DM, Ryan JL, Mansour TS.
    Bioorg Med Chem; 2004 Nov 15; 12(22):5807-17. PubMed ID: 15498657
    [Abstract] [Full Text] [Related]

  • 37. Amino acid substitutions at positions 69, 165, 244 and 275 of the PER-1beta-lactamase do not impair enzyme inactivation by clavulanate.
    Bouthors AT, Jarlier V, Sougakoff W.
    J Antimicrob Chemother; 1998 Sep 15; 42(3):399-401. PubMed ID: 9786485
    [No Abstract] [Full Text] [Related]

  • 38. Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene.
    Vakulenko SB, Geryk B, Kotra LP, Mobashery S, Lerner SA.
    Antimicrob Agents Chemother; 1998 Jul 15; 42(7):1542-8. PubMed ID: 9660980
    [Abstract] [Full Text] [Related]

  • 39. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
    Acar N, Diri MC, Türkyilmaz FR.
    Mikrobiyol Bul; 1987 Oct 15; 21(4):284-8. PubMed ID: 3332705
    [Abstract] [Full Text] [Related]

  • 40. [Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral formulations as well as in body fluids and tissue homogenates. Comparison of sulbactam, clavulanic acid, ampicillin and amoxicillin].
    Wildfeuer A, Räder K.
    Arzneimittelforschung; 1991 Jan 15; 41(1):70-3. PubMed ID: 2049115
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.